Arran Chemical Company Completes Stage II of its Strategic Plan “ADAPT”
Completion of multi-million Euro expansion of manufacturing capacity and deployment of next generation production technologies
|Athlone, Ireland, 09 October 2018 – as reported in October 2017, Irish based Arran Chemical Company, has responded to client demand for the provision of fine chemicals, pharmaceutical intermediates and advanced building blocks by implementation of its three stage ADAPT (Arran Deploys Advanced Production Technologies) strategy through a multi-million Euro investment. The investment is focused around increasing capacity, further application of its selectAZyme™ biocatalysis technology and implementation of flow chemistry. Arran is proud to announce the completion of Stage II of the strategy and the positive benefit to its global client base.|
Almac Group Announces Successful HPRA Inspection at its European Campus
Craigavon, N.I., UK, 02 October 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection of Almac Pharma Services (Ireland) at its European campus in Dundalk, Ireland, by the Health Products Regulatory Authority (HPRA).
Almac Group Launches Global Analytical Services Capability
Craigavon, N.I., 01 Oct 2018 – Almac Group, the global contract development and manufacturing organisation, is delighted to announce its global analytical services capabilities spanning UK, Europe and North America.
Following the successful acquisition of BioClin Research Laboratories in 2017, Almac’s Sciences Business Unit has united its world-class capabilities to form an analytical group which can meet the varying demands required within its clients’ development programs. From 1st October, BioClin will rename under the Almac Sciences brand, further strengthening its offering and presenting a unified platform within the pharmaceutical industry.
Six Irish men to share $635m after sale of drug firm
Irish Times Business
Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States
Six Irish businessmen will share a $635 million (€542m) payday after selling a company that developed a drug used in the frontline as the United States battles an opioid crisis.
Waterford entrepreneur Seamus Mulligan and his team invested €115 million to set up Adapt Pharma just over four years ago. Their team focused on a drug, Naloxone, that has been in use for many years and is commonly used in hospital anaesthesia.
To read more, please click HERE.
Welcome to new members, Pendulum Summit, a Dublin-based company founded by Irish Rugby star Frankie Sheahan. Pendulum is the world’s leading business and self-empowerment summit.
Through Pendulum new membership in the Irish Chamber, we are delighted to offer all IABCN members a special discount on tickets to Pendulum Summit New York on September 13th at the PlayStation Theater in Times Square. This is a highly anticipated one day event that brings together hundreds of senior-level decision makers from across all industries to learn from and be inspired by some of the world’s most renowned figures from business and self-empowerment.
Offering a unique blend of ideas and inspiration, Pendulum Summit focuses on the issues most relevant to today’s business people, stimulating new thinking and motivating action. As the world’s leading business and self-empowerment summit, transforming the lives of 16,000+ attendees through its previous five sell out summits in Ireland, Pendulum Summit has chosen New York as part of its global mission.